LifeMD Price to Sales Ratio vs Gross Profit Analysis

LFMD Stock

USD 10.21 0.34 3.44%

LifeMD financial indicator trend analysis is infinitely more than just investigating LifeMD Inc recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether LifeMD Inc is a good investment. Please check the relationship between LifeMD Price To Sales Ratio and its Gross Profit accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in LifeMD Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.

Price To Sales Ratio vs Gross Profit

Price to Sales Ratio vs Gross Profit Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of LifeMD Inc Price to Sales Ratio account and Gross Profit. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between LifeMD's Price to Sales Ratio and Gross Profit is -0.47. Overlapping area represents the amount of variation of Price to Sales Ratio that can explain the historical movement of Gross Profit in the same time period over historical financial statements of LifeMD Inc, assuming nothing else is changed. The correlation between historical values of LifeMD's Price to Sales Ratio and Gross Profit is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Price to Sales Ratio of LifeMD Inc are associated (or correlated) with its Gross Profit. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Gross Profit has no effect on the direction of Price to Sales Ratio i.e., LifeMD's Price to Sales Ratio and Gross Profit go up and down completely randomly.

Correlation Coefficient

-0.47

Relationship Direction	Negative
Relationship Strength	Very Weak

View All Relationships

Price To Sales Ratio

Price to Sales Ratio is figured by comparing LifeMD Inc stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on LifeMD sales, a figure that is much harder to manipulate than other LifeMD Inc multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company’s stock price to its revenues, calculated by dividing the company’s market cap by its total sales or revenue over a 12-month period.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of LifeMD Inc minus its cost of goods sold. It is profit before LifeMD operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Most indicators from LifeMD's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into LifeMD Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in LifeMD Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.

At present, LifeMD's Discontinued Operations is projected to increase significantly based on the last few years of reporting. The current year's Tax Provision is expected to grow to about 449.4 K, whereas Sales General And Administrative To Revenue is forecasted to decline to 0.32.

	2021	2022	2023	2024 (projected)
Gross Profit	74.9M	100.4M	126.0M	132.3M
Total Revenue	92.9M	119.0M	152.5M	160.2M

Gross Profit Total Revenue

LifeMD fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Common Stock	Current Deferred Revenue	Other Current Assets	Net Tangible Assets
Total Assets		0.86	0.95	0.94	0.48	0.76	-0.76	-0.94	0.88	0.96	0.88	0.96	0.89	0.03	0.95	0.84	0.81	0.97	0.95	0.76	0.99	0.39	0.07	0.89	0.95	-0.34
Short Long Term Debt Total	0.86		0.82	0.84	0.07	0.4	-0.37	-0.82	0.72	0.74	0.89	0.74	0.97	0.13	0.83	1.0	0.72	0.84	0.93	0.4	0.8	0.26	0.18	0.95	0.93	-0.66
Other Current Liab	0.95	0.82		0.97	0.34	0.83	-0.65	-0.97	0.88	0.85	0.94	0.85	0.89	0.11	0.99	0.77	0.91	0.98	0.96	0.83	0.9	0.61	0.14	0.91	0.95	-0.45
Total Current Liabilities	0.94	0.84	0.97		0.24	0.79	-0.59	-1.0	0.95	0.81	0.96	0.81	0.92	0.0	0.99	0.79	0.94	1.0	0.98	0.79	0.88	0.65	0.04	0.94	0.92	-0.55
Total Stockholder Equity	0.48	0.07	0.34	0.24		0.54	-0.92	-0.25	0.29	0.7	0.04	0.7	0.04	-0.08	0.3	0.08	0.07	0.32	0.2	0.54	0.61	-0.19	-0.07	0.03	0.28	0.66
Property Plant And Equipment Net	0.76	0.4	0.83	0.79	0.54		-0.74	-0.81	0.74	0.72	0.68	0.72	0.54	-0.17	0.81	0.34	0.75	0.81	0.68	1.0	0.74	0.68	-0.15	0.58	0.65	-0.09
Net Debt	-0.76	-0.37	-0.65	-0.59	-0.92	-0.74		0.6	-0.63	-0.9	-0.39	-0.9	-0.38	0.1	-0.62	-0.37	-0.41	-0.65	-0.54	-0.74	-0.85	-0.08	0.08	-0.38	-0.58	-0.34
Retained Earnings	-0.94	-0.82	-0.97	-1.0	-0.25	-0.81	0.6		-0.94	-0.81	-0.96	-0.81	-0.91	0.02	-0.99	-0.77	-0.94	-1.0	-0.97	-0.81	-0.88	-0.66	-0.02	-0.93	-0.91	0.54
Accounts Payable	0.88	0.72	0.88	0.95	0.29	0.74	-0.63	-0.94		0.79	0.83	0.79	0.8	-0.05	0.92	0.67	0.89	0.93	0.9	0.74	0.84	0.62	-0.02	0.82	0.82	-0.44
Cash	0.96	0.74	0.85	0.81	0.7	0.72	-0.9	-0.81	0.79		0.7	1.0	0.73	-0.01	0.84	0.73	0.63	0.86	0.83	0.72	0.99	0.18	0.03	0.72	0.86	-0.06
Non Current Assets Total	0.88	0.89	0.94	0.96	0.04	0.68	-0.39	-0.96	0.83	0.7		0.7	0.96	0.07	0.95	0.85	0.93	0.95	0.97	0.68	0.78	0.65	0.11	0.98	0.92	-0.71
Cash And Short Term Investments	0.96	0.74	0.85	0.81	0.7	0.72	-0.9	-0.81	0.79	1.0	0.7		0.73	-0.01	0.84	0.73	0.63	0.86	0.83	0.72	0.99	0.18	0.03	0.72	0.86	-0.06
Net Receivables	0.89	0.97	0.89	0.92	0.04	0.54	-0.38	-0.91	0.8	0.73	0.96	0.73		0.1	0.91	0.95	0.84	0.91	0.97	0.54	0.81	0.45	0.14	0.99	0.93	-0.71
Common Stock Total Equity	0.03	0.13	0.11	0.0	-0.08	-0.17	0.1	0.02	-0.05	-0.01	0.07	-0.01	0.1		0.05	0.15	0.18	-0.01	0.05	-0.17	0.02	0.01	1.0	0.07	0.19	-0.09
Common Stock Shares Outstanding	0.95	0.83	0.99	0.99	0.3	0.81	-0.62	-0.99	0.92	0.84	0.95	0.84	0.91	0.05		0.78	0.94	0.99	0.97	0.81	0.9	0.63	0.09	0.93	0.93	-0.5
Non Current Liabilities Total	0.84	1.0	0.77	0.79	0.08	0.34	-0.37	-0.77	0.67	0.73	0.85	0.73	0.95	0.15	0.78		0.66	0.79	0.9	0.34	0.79	0.17	0.2	0.92	0.91	-0.62
Inventory	0.81	0.72	0.91	0.94	0.07	0.75	-0.41	-0.94	0.89	0.63	0.93	0.63	0.84	0.18	0.94	0.66		0.92	0.89	0.75	0.72	0.81	0.2	0.87	0.83	-0.63
Other Stockholder Equity	0.97	0.84	0.98	1.0	0.32	0.81	-0.65	-1.0	0.93	0.86	0.95	0.86	0.91	-0.01	0.99	0.79	0.92		0.98	0.81	0.92	0.6	0.02	0.93	0.93	-0.49
Total Liab	0.95	0.93	0.96	0.98	0.2	0.68	-0.54	-0.97	0.9	0.83	0.97	0.83	0.97	0.05	0.97	0.9	0.89	0.98		0.68	0.89	0.52	0.09	0.98	0.96	-0.6
Property Plant And Equipment Gross	0.76	0.4	0.83	0.79	0.54	1.0	-0.74	-0.81	0.74	0.72	0.68	0.72	0.54	-0.17	0.81	0.34	0.75	0.81	0.68		0.74	0.68	-0.15	0.58	0.65	-0.09
Total Current Assets	0.99	0.8	0.9	0.88	0.61	0.74	-0.85	-0.88	0.84	0.99	0.78	0.99	0.81	0.02	0.9	0.79	0.72	0.92	0.89	0.74		0.27	0.06	0.8	0.91	-0.18
Short Term Debt	0.39	0.26	0.61	0.65	-0.19	0.68	-0.08	-0.66	0.62	0.18	0.65	0.18	0.45	0.01	0.63	0.17	0.81	0.6	0.52	0.68	0.27		0.02	0.53	0.42	-0.55
Common Stock	0.07	0.18	0.14	0.04	-0.07	-0.15	0.08	-0.02	-0.02	0.03	0.11	0.03	0.14	1.0	0.09	0.2	0.2	0.02	0.09	-0.15	0.06	0.02		0.11	0.23	-0.12
Current Deferred Revenue	0.89	0.95	0.91	0.94	0.03	0.58	-0.38	-0.93	0.82	0.72	0.98	0.72	0.99	0.07	0.93	0.92	0.87	0.93	0.98	0.58	0.8	0.53	0.11		0.94	-0.73
Other Current Assets	0.95	0.93	0.95	0.92	0.28	0.65	-0.58	-0.91	0.82	0.86	0.92	0.86	0.93	0.19	0.93	0.91	0.83	0.93	0.96	0.65	0.91	0.42	0.23	0.94		-0.51
Net Tangible Assets	-0.34	-0.66	-0.45	-0.55	0.66	-0.09	-0.34	0.54	-0.44	-0.06	-0.71	-0.06	-0.71	-0.09	-0.5	-0.62	-0.63	-0.49	-0.6	-0.09	-0.18	-0.55	-0.12	-0.73	-0.51

Click cells to compare fundamentals

LifeMD Account Relationship Matchups

LifeMD fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	3.4M	13.1M	49.9M	25.7M	58.5M	61.4M
Short Long Term Debt Total	844.7K	1.1M	1.8M	4.1M	18.9M	19.9M
Other Current Liab	3.1M	1.4M	11.6M	12.2M	13.9M	14.6M
Total Current Liabilities	4.0M	13.5M	22.8M	31.4M	34.8M	36.5M
Total Stockholder Equity	(988.2K)	1.4M	26.9M	(6.8M)	3.5M	2.1M
Net Debt	(261.9K)	(8.1M)	(39.5M)	168.5K	(14.2M)	(13.5M)
Retained Earnings	(16.6M)	(80.2M)	(141.9M)	(190.6M)	(214.3M)	(203.6M)
Accounts Payable	3.1M	10.4M	9.1M	10.1M	11.1M	11.6M
Cash	1.1M	9.2M	41.3M	4.0M	33.1M	34.8M
Non Current Assets Total	699.1K	990.3K	5.0M	14.4M	15.9M	16.7M
Cash And Short Term Investments	1.1M	9.2M	41.3M	4.0M	33.1M	34.8M
Net Receivables	97.4K	648.4K	980.1K	2.8M	5.3M	5.5M
Common Stock Total Equity	534.0K	234.3K	307.0K	315.5K	362.9K	377.1K
Common Stock Shares Outstanding	9.9M	14.3M	27.0M	31.0M	33.9M	35.6M
Liabilities And Stockholders Equity	3.4M	13.1M	49.9M	25.7M	58.5M	61.4M
Non Current Liabilities Total	600.0K	385.3K	1.3M	1.6M	18.1M	19.0M
Inventory	950.1K	1.3M	1.6M	3.7M	2.8M	2.9M
Other Stockholder Equity	15.1M	77.6M	164.4M	178.9M	217.4M	228.3M
Total Liab	4.6M	13.9M	24.1M	33.0M	52.9M	55.6M
Total Current Assets	2.7M	12.1M	44.9M	11.3M	42.6M	44.7M
Short Term Debt	814.7K	779.1K	670.9K	3.6M	930.8K	715.0K
Common Stock	534.0K	234.3K	307.0K	315.5K	383.6K	380.6K
Current Deferred Revenue	109.6K	916.9K	1.5M	5.5M	8.8M	9.3M
Other Current Assets	443.0K	154.9K	793.2K	687.0K	1.4M	1.5M
Net Tangible Assets	(1.7M)	(3.0M)	19.7M	(19.5M)	(17.6M)	(16.7M)
Net Invested Capital	(173.5K)	(1.5M)	22.8M	(8.6M)	21.8M	22.8M
Short Long Term Debt	814.7K	779.1K	63.4K	2.8M	327.6K	311.2K
Net Working Capital	(1.2M)	(1.4M)	22.1M	(20.1M)	7.8M	8.2M
Capital Stock	534.0K	3.9M	4.4M	4.9M	383.7K	364.5K
Intangible Assets	675.5K	715.8K	3.0M	12.7M	14.8M	15.5M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether LifeMD Inc is a strong investment it is important to analyze LifeMD's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact LifeMD's future performance. For an informed investment choice regarding LifeMD Stock, refer to the following important reports:

How To Invest In LifeMD

Details

Is LifeMD Stock a good investment?

Details

What is LifeMD's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in LifeMD Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.

You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Complementary Tools for LifeMD Stock analysis

When running LifeMD's price analysis, check to measure LifeMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LifeMD is operating at the current time. Most of LifeMD's value examination focuses on studying past and present price action to predict the probability of LifeMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LifeMD's price. Additionally, you may evaluate how the addition of LifeMD to your portfolios can decrease your overall portfolio volatility.

	Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
	Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
	Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
	Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
	Insider Screener Find insiders across different sectors to evaluate their impact on performance
	Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges
	Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance

Is LifeMD's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of LifeMD. If investors know LifeMD will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about LifeMD listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.70)

Revenue Per Share

4.499

Quarterly Revenue Growth

0.595

Return On Assets

(0.22)

Return On Equity

(7.82)

The market value of LifeMD Inc is measured differently than its book value, which is the value of LifeMD that is recorded on the company's balance sheet. Investors also form their own opinion of LifeMD's value that differs from its market value or its book value, called intrinsic value, which is LifeMD's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because LifeMD's market value can be influenced by many factors that don't directly affect LifeMD's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between LifeMD's value and its price as these two are different measures arrived at by different means. Investors typically determine if LifeMD is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, LifeMD's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

LifeMD Price to Sales Ratio vs Gross Profit Analysis

Price To Sales Ratio vs Gross Profit

Price to Sales Ratio vs Gross Profit Correlation Analysis

Correlation Coefficient

Price To Sales Ratio

Gross Profit

LifeMD fundamental ratios Correlations

LifeMD Account Relationship Matchups

High Positive Relationship

High Negative Relationship

LifeMD fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for LifeMD Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Liabilities Total	+ 1.0	Short Long Term Debt Total
Other Stockholder Equity	+ 1.0	Total Current Liabilities
Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Cash And Short Term Investments	+ 1.0	Cash
Common Stock	+ 1.0	Common Stock Total Equity
Total Current Assets	+ 0.99	Total Assets

Other Stockholder Equity	- 1.0	Retained Earnings
Retained Earnings	- 1.0	Total Current Liabilities
Common Stock Shares Outstanding	- 0.99	Retained Earnings
Total Liab	- 0.97	Retained Earnings
Retained Earnings	- 0.97	Other Current Liab
Non Current Assets Total	- 0.96	Retained Earnings